Cristina Fernández‐Fernández

Performance of Probabilistic Method to Detect Duplicate Individual Case Safety Reports

Philip Tregunno, Dorthe Bech Fink, Cristina Fernández‐Fernández et al. · Drug Safety · 2014 · 80 citations

Reliability, Engineering, Data Mining +8

Synthesis and pharmacological studies of new hybrid derivatives of fentanyl active at the μ-opioid receptor and I2–imidazoline binding sites

Christophe Dardonville, Cristina Fernández‐Fernández, Sarah-Louise Gibbons et al. · Bioorganic & Medicinal Chemistry · 2006 · 46 citations

Molecular Pharmacology, μ-Opioid Receptor, Derivatives +11

Antiprotozoal Activity of 1-Phenethyl-4-Aminopiperidine Derivatives

Christophe Dardonville, Cristina Fernández‐Fernández, Sarah-Louise Gibbons et al. · Antimicrobial Agents and Chemotherapy · 2009 · 21 citations · Full text

Combining rimonabant and fentanyl in a single entity: preparation and pharmacological results

Nadine Jagerovic, Cristina Fernández‐Fernández, Amaia M. Erdozain et al. · Drug Design Development and Therapy · 2014 · 16 citations · Full text

Quantity is not enough: completeness of suspected adverse drug reaction reports in Spain—differences between regional pharmacovigilance centres and pharmaceutical industry

Cristina Fernández‐Fernández, Edurne Lázaro‐Bengoa, E. Fernández-Antón et al. · European Journal of Clinical Pharmacology · 2020 · 16 citations

Drug Safety, Drug Interactions, Regional Pharmacovigilance Centres +10